These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1504304)

  • 1. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
    Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC
    Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoproteins enhance tissue factor-independent factor VII activation.
    Kjalke M; Silveira A; Hamsten A; Hedner U; Ezban M
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1835-41. PubMed ID: 10894826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
    Osterud B; Rapaport SI
    Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
    Liu DY; Rosen S
    Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
    Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
    J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced inhibition of tissue factor by the extended form of an endothelial cell glycoprotein (an extrinsic pathway inhibitor).
    Colburn P; Crabb JW; Buonassisi V
    J Cell Physiol; 1991 Aug; 148(2):320-6. PubMed ID: 1880157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.